BridgeMD
New treatment option for Atrial Fibrillation
Official title QOL Improvement After Cardioversion of Persistent AF (QOL-CAFRCT)
ClinicalTrials.gov ID: NCT05136131
What this study is testing
- What it's testing
- Atrial fibrillation (AF) is a type of irregular heart rhythm due to electrical signal disturbances of the heart. It is a very common arrhythmia and the risk of developing AF increases with age and with other risk factors such as diabetes, high blood pressure, and underlying heart disease.
- You might receive a placebo (an inactive treatment) instead of the study drug, decided by chance. You may not know which one you got.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Patients age ≥ 18 years
- Persistent atrial fibrillation
- Unknown symptom burden related to AF
You likely can't join if
- Known left-atrial appendage thrombus
- Prior catheter or surgical ablation for AF
- Intolerance or contraindication to Amiodarone
- Contraindication to appropriate anticoagulation
- Patient is included in another assigned by chance clinical trial
- Patient is unable or unwilling to provide informed consent
See the full eligibility criteria
- Patients age ≥ 18 years
- Persistent atrial fibrillation
- Unknown symptom burden related to AF
- Known left-atrial appendage thrombus
- Prior catheter or surgical ablation for AF
- Intolerance or contraindication to Amiodarone
- Contraindication to appropriate anticoagulation
- Patient is included in another assigned by chance clinical trial
- Patient is unable or unwilling to provide informed consent
- Patient with a history of noncompliance with medical therapy
- Patient does not meet all of the above listed inclusion criteria
- Pregnancy (all women of child bearing age and potential will have a negative BHCG test before enrolment)
- Breastfeeding
- Patients for whom the investigator believes that the trial is not in the interest of the patient
The study team makes the final eligibility decision.
Where it's taking place
- Newmarket, Ontario, Canada
- Ottawa, Ontario, Canada
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Newmarket, Ontario, Canada; Ottawa, Ontario, Canada. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.